Currently there is expanding interest, from the perspectives of occupational health surveillance and future epidemiological research, in early monitoring of worker exposure to engineered nanomaterials. Here, we highlight quantitative systemic markers in mice after a single exposure to carbon nanotubes (CNT) (multi-walled (MW) CNT or single-walled (SW) CNT). Mice were exposed by pharyngeal aspiration to 40microg and harvested at 24 hr, 7 and 28d post exposure. Mice were sacrificed and the following parameters were analyzed: whole blood gene expression, blood and bronchoalveolar lavage (BAL) differentials, serum protein profiling by immunoplex and proteomics, and gene expression analysis in the lung and extrapulmonary tissues including aorta, heart and liver. Early effects of pulmonary CNT exposure include a rapid but transient increase in inflammatory blood gene expression (IL-1beta, CXCL2) and serum cytokines (IL-6, IL-5, CCL11). This was followed by an acute phase response including CRP, SAA-1, SAP and haptoglobin as shown by elevated serum protein levels and liver gene expression. Beyond 24hr there was a consistent increase in both blood and BAL eosinophils. These data correspond well with early increased serum IL-5 and CCL11 after MWCNT exposure. At 28d, serum acute phase proteins with immune function including complement C3, apolipoprotein A-I and A-II, alpha2-marcoglobulin, serotransferrin and liver carboxylesterase N were increased. The systemic markers correlated well with existing literature showing end-point measurements of pulmonary CNT exposure and adverse cardiovascular effects and enhanced allergic response.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.